Skip to main content
Clinical Trials/NCT01326351
NCT01326351
Unknown
Phase 4

Plantar Fasciitis: Pain Relief and Improvement of Foot Function With Prolotherapy

Réseau de Santé Vitalité Health Network1 site in 1 country60 target enrollmentMay 2011

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Plantar Fasciitis
Sponsor
Réseau de Santé Vitalité Health Network
Enrollment
60
Locations
1
Primary Endpoint
Assessment of pain and function of the affected foot during the course of treatment
Last Updated
15 years ago

Overview

Brief Summary

The purpose of this study is to demonstrate that prolotherapy in conjunction with a physiotherapy program looking at reinforcing calf muscle and muscle of the plantar fascia, relieves pain and improves function of people suffering of plantar fasciitis, an inflammation of the plantar fascia, after basic treatment failure.

Registry
clinicaltrials.gov
Start Date
May 2011
End Date
February 2012
Last Updated
15 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Réseau de Santé Vitalité Health Network

Eligibility Criteria

Inclusion Criteria

  • have a diagnosis of Plantar Fasciitis
  • experience pain in the plantar fascia for more than 6 months
  • be capable to understand and execute physiotherapy exercises

Exclusion Criteria

  • previous operation of the plantar fascia
  • deformation of the foot (congenital or acquired)
  • presence or suspicion of infection of the skin at the site where the injection will occur
  • history of systemic diseases capable of inducing pain or sensitivity to the feet (seronegative arthritis, diabetes, fibromyalgia, etc.)
  • abnormal coagulation
  • allergy to lidocaine and/or marcaine
  • pregnancy
  • lumbar, hip or knee pain

Outcomes

Primary Outcomes

Assessment of pain and function of the affected foot during the course of treatment

Time Frame: Every 3 weeks from week 0 to 36

The Maryland Foot Score questionnaire will be used. This questionnaire assesses pain and function of injured foot using a summated rating scale of 10 questions.

Secondary Outcomes

  • Assessment of pain intensity and pain-related function impairment during the course of treatment(Every 3 weeks from week 0 to 36)

Study Sites (1)

Loading locations...

Similar Trials